COP, cryptogenic organizing pneumonia; CT, computed tomography; GGO, ground-glass opacities; T-DXd, trastuzumab deruxtecan. Fig 2. COP pattern of pneumonitis in a 76-year-old woman with breast cancer ...

Trastuzumab deruxtecan plus pertuzumab demonstrated statistically and clinically significant improvement in progression-free ...

Adjudicated drug-related interstitial lung disease or pneumonitis occurred in 13.9% of the patients who received trastuzumab deruxtecan (grade 1 or 2 in 33 patients and grade 3 in 1) and in 1.3% ...

A higher percentage of patients assigned trastuzumab deruxtecan experienced interstitial lung disease/pneumonitis (15.2% vs. 3.1%); however, cases were mild or moderate, Hurvitz said.

A total of 12 patients had trastuzumab deruxtecan–related interstitial lung disease or pneumonitis (grade 1 or 2 in 9 patients and grade 3 or 4 in 3), as adjudicated by an independent committee.

Trastuzumab deruxtecan belongs to a group of antineoplastic drugs known as antibody-drug conjugates (ADCs). This type of treatment combines two therapies into one.

WILMINGTON, Del.--(BUSINESS WIRE)--High-level results from the primary analysis of the ongoing DESTINY-PanTumor02 Phase II trial showed ENHERTU ® (fam-trastuzumab deruxtecan-nxki) demonstrated ...

--(BUSINESS WIRE)-- Positive high-level results from a planned interim analysis of the DESTINY-Breast09 Phase III trial showed ENHERTU® (fam-trastuzumab deruxtecan-nxki) in combination with ...

Get 7 Days Free Sign In Sign In Topics ...

Patterns of Treatment Failure After Selective Rearranged During Transfection (RET) Inhibitors in Patients With Metastatic Medullary Thyroid Carcinoma Ninety patients with advanced cancers who ...